Summit Healthcare to acquire YS Biopharma in a deal valued at $834M (NASDAQ:SMIH)

Special purpose acquisition firm (SPAC) Summit Healthcare Acquisition (SMIH) said on Thursday it would acquire drug maker YS Biopharma in a transaction that is valued at about...

Related Keywords

China ,Philippines ,United States ,United Arab Emirates ,Singapore ,Yi Zhang ,Shaanxi ,Maksim Labkouski ,Nasdaq ,Ys Biopharma Co Ltd ,Summit Healthcare Acquisition ,Forward Purchase Investors ,